Dexterra Group Inc. Announces Results for Q4 and Year Ended December 31, 2024
Rhea-AI Summary
Dexterra Group reported strong financial results for 2024, with consolidated revenue reaching $1.0 billion, an 8.1% increase from 2023. The company's Q4 2024 revenue was $247.8 million, up by $16.6 million compared to Q4 2023.
Key financial highlights include:
- Adjusted EBITDA from continuing operations at $107.4 million in 2024
- Support Services achieved record EBITDA of $74.1 million, up 36.8%
- Free Cash Flow improved to $74.7 million, with 69.5% EBITDA conversion
- Net earnings from continuing operations reached $37.5 million
- Earnings per share increased to $0.58 in 2024 from $0.55 in 2023
The company continued its share buyback program, purchasing 1,177,100 shares at an average price of $6.72. A Q1 2025 dividend of $0.0875 per share was declared, payable April 15, 2025.
Positive
- Revenue growth of 8.1% to $1.0 billion in 2024
- Support Services EBITDA increased 36.8% to record $74.1 million
- Free Cash Flow improved to $74.7 million from $57.8 million
- Strong EBITDA conversion rate of 69.5%
- Net earnings increased to $37.5 million from $35.8 million
- Active share buyback program with 1.17M shares purchased
Negative
- Asset Based Services EBITDA declined significantly in 2024
- ABS revenue decreased to $191.8 million from $192.9 million
- Q4 ABS revenues dropped to $41.3M from $56.5M in Q4 2023
- Q4 net earnings declined to $7.6M from $8.3M in Q4 2023
News Market Reaction 1 Alert
On the day this news was published, HZNOF declined 9.81%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Toronto, Ontario--(Newsfile Corp. - March 6, 2025) - Dexterra Group Inc. (TSX: DXT)
Highlights
Dexterra generated strong results from continuing operations for 2024 with consolidated revenue of
$1.0 billion , an increase of8.1% compared to the prior year. The increase in revenue was due to organic growth, strong natural resource market activity levels and the contribution from the CMI Management LLC ("CMI") acquisition. For Q4 2024, Dexterra generated consolidated revenue of$247.8 million , an increase of$16.6 million , compared to Q4 2023. The increase was driven by the above, partially offset by lower camp demobilization and installation project activity in Asset Based Services ("ABS") compared to Q4 2023.Adjusted EBITDA from continuing operations for 2024 was
$107.4 million (2023 -$106.8 million ). Support Services ("SS") EBITDA rose significantly to a record$74.1 million , an increase of36.8% . This was offset by lower 2024 EBITDA from ABS as expected due to the abnormal level of wildfire activity in 2023. These 2024 developments were consistent with management's plans to increase the scale and profitability of the Support Services business. Adjusted EBITDA for Q4 2024 was$26.6 million compared to$23.6 million in Q4 2023. This increase is a result of stronger revenues and margins in Support Services offset by lower volumes in ABS as several large projects were demobilized in Q4 2023.Free Cash Flow ("FCF") was
$74.7 million for the year ended December 31, 2024, compared to$57.8 million in 2023. The Adjusted EBITDA conversion to FCF was69.5% as compared to54.1% in the prior year and reflected strong operating results and working capital management and nominal cash taxes payable as the company utilized tax loss carryforwards.For the three months and year ended December 31, 2024, net earnings from continuing operations were
$7.6 million and$37.5 million , respectively, compared to$8.3 million and$35.8 million in 2023. Our continuing operations delivered a return on equity of13.3% in 2024 and12.5% in 2023. Earnings per share from continuing operations was$0.58 cents in 2024 compared to$0.55 cents in 2023.In connection with the ongoing Normal Course Issuer Bid ("NCIB"), Dexterra purchased and cancelled 1,177,100 common shares in 2024 at a weighted average price of
$6.72 per share for a total consideration of$7.9 million . Dexterra plans to remain opportunistic with share buybacks in 2025 as we believe our shares are undervalued.Dexterra paid dividends of
$0.35 during the year and declared a dividend for Q1 2025 of$0.08 75 per share for shareholders of record at March 31, 2025, to be paid April 15, 2025.In Q4 2024, Dexterra repositioned its business from an operational and external segmented reporting perspective into SS and ABS.
This news release contains certain measures and ratios, such as Adjusted EBITDA, Adjusted EBITDA as a percentage of revenue, Return on Equity, and Free Cash Flow that do not have any standardized meaning as prescribed by GAAP and, therefore, are considered non-GAAP measures. The method of calculating these measures may differ from other entities and accordingly, may not be comparable to measures used by other entities. See "Non-GAAP measures" and "Reconciliation of Non-GAAP measures" of the Corporation's MD&A for the three months and year ended December 31, 2024 and 2023 details which is incorporated by reference herein.
Fourth Quarter and Annual Financial Summary
| Three months ended December 31, | Years ended December 31, | |||||||||||
| (000's except per share amounts) | 2024 | 2023(1) | 2024 | 2023(1) | ||||||||
| Revenue | $ | 247,758 | $ | 231,196 | $ | 1,003,027 | $ | 927,776 | ||||
| Adjusted EBITDA(2) | 26,558 | 23,567 | 107,438 | 106,774 | ||||||||
| Adjusted EBITDA as a % of revenue(2) | | | | | ||||||||
| Net earnings from continuing operations(1)(3) | 7,584 | 8,291 | 37,540 | 35,810 | ||||||||
| Net loss from discontinued operations, net of income taxes(4) | (669 | ) | (8,594) | (17,447 | ) | (9,060 | ) | |||||
| Net earnings (loss)(3) | 6,915 | (303 | ) | 20,093 | 26,750 | |||||||
| Earnings (loss) per share | ||||||||||||
| Net earnings from continuing operations per share, basic and diluted | 0.11 | 0.13 | 0.58 | 0.55 | ||||||||
| Total net earnings per share, basic and diluted | 0.11 | 0.00 | 0.31 | 0.41 | ||||||||
| Total assets | 524,890 | 607,088 | 524,890 | 607,088 | ||||||||
| Total loans and borrowings ("Net Debt") | 67,859 | 89,615 | 67,859 | 89,615 | ||||||||
| Free Cash Flow(2) | 52,701 | 57,133 | 74,680 | 57,783 | ||||||||
(1) The comparative numbers have been restated as the Modular business was classified to discontinued operations in Q1 2024.
(2) Please refer to the "Non-GAAP measures" section for the definition of Adjusted EBITDA, Adjusted EBITDA as a percentage of revenue, and Free Cash Flow and to the "Reconciliation of non-GAAP measures" section for the related calculations.
(3) Acquisition costs in pre-tax earnings for the three months and year ended December 31, 2024, were $nil and
(4) Net loss from discontinued operations includes
Fourth Quarter and Annual Operational Analysis
| Three months ended December 31, | Years ended December 31, | |||||||||||
| (000's) | 2024 | 2023 | 2024 | 2023 | ||||||||
| Revenue: | ||||||||||||
| Support Services | $ | 206,472 | $ | 174,659 | $ | 811,180 | $ | 734,340 | ||||
| Asset Based Services | 41,286 | 56,537 | 191,847 | 192,936 | ||||||||
| Corporate, Other and Inter-segment eliminations | - | - | - | 500 | ||||||||
| Total Revenue | $ | 247,758 | $ | 231,196 | $ | 1,003,027 | $ | 927,776 | ||||
| Adjusted EBITDA: | ||||||||||||
| Support Services | $ | 18,209 | $ | 12,203 | $ | 74,133 | $ | 54,205 | ||||
| Asset Based Services | 13,896 | 15,596 | 56,215 | 70,896 | ||||||||
| Corporate, Other and Inter-segment eliminations | (5,547 | ) | (4,232 | ) | (22,910 | ) | (18,327 | ) | ||||
| Total Adjusted EBITDA | $ | 26,558 | $ | 23,567 | $ | 107,438 | $ | 106,774 | ||||
| Adjusted EBITDA as a % of Revenue | ||||||||||||
| Support Services | 8.8 % | 7.0 % | 9.1 % | 7.4 % | ||||||||
| Asset Based Services | 33.7 % | 27.6 % | 29.3 % | 36.7 % | ||||||||
Support Services
Revenue for the year ended December 31, 2024 was
Adjusted EBITDA for the year ended December 31, 2024 was
For Q4 2024, Support Services revenues were
Asset Based Services
Revenue for the year ended December 31, 2024 was
Adjusted EBITDA for the year ended December 31, 2024 was
For Q4 2024, ABS revenues were
Liquidity and Capital Resources
Debt was
Additional Information
A copy of Dexterra's Consolidated Financial Statements ("Financial Statements") for the years ended December 31, 2024 and 2023 and related Management's Discussion and Analysis ("MD&A") have been filed with the Canadian Securities Regulatory authorities and are available on SEDAR at sedarplus.ca and Dexterra's website at dexterra.com. The Financial Statements have been prepared in accordance with International Financial Reporting Standards and the reporting currency is in Canadian dollars. Additional history of comparative information under our new segmentation is also available on our website under Investors & Governance and is for informational purposes only.
Conference Call
Dexterra will host a conference call and webcast to begin promptly at 8:30 a.m. Eastern Time on March 7, 2025 to discuss the 2024 year-end and fourth quarter results.
To access the conference call by telephone the conference call dial in number is 1-844-763-8274
A live webcast of the conference call will be accessible on Dexterra's website at dexterra.com/investor-presentations-events by selecting the webcast link. An archived recording of the conference call will be available approximately one hour after the completion of the call until April 6, 2025, by dialing 1- 855-669-9658, passcode 3578869.
About Dexterra
Dexterra employs more than 9,000 people, delivering a range of support services for the creation, management, and operation of infrastructure across Canada and the U.S.
Powered by people, Dexterra brings best-in-class regional expertise to every challenge and delivers innovative solutions, giving clients confidence in their day-to-day operations. Activities include a comprehensive range of integrated facilities management services, industry-leading workforce accommodation solutions and other support services for diverse clients in the public and private sectors.
For further information contact:
Denise Achonu, CFO
Head office: Airway Centre, 5925 Airport Rd., Suite 1000
Mississauga, Ontario L4V 1W1
Telephone: (905) 270-1964
You can also visit our website at dexterra.com
Reconciliation of non-GAAP measures
The following provides a reconciliation of non-GAAP measures to the nearest measure under GAAP for items presented throughout the news release:
Adjusted EBITDA
| Three months ended December 31, | Years ended December 31, | |||||||||||
| (000's) | 2024 | 2023 | 2024 | 2023 | ||||||||
| Net earnings from continuing operations | $ | 7,584 | $ | 8,291 | $ | 37,540 | $ | 35,810 | ||||
| Add: | ||||||||||||
| Share based compensation (recovery) | 1,200 | (236 | ) | 4,557 | 1,778 | |||||||
| Depreciation & amortization | 9,612 | 8,661 | 35,205 | 34,975 | ||||||||
| Equity investment depreciation | 87 | 439 | 974 | 1,613 | ||||||||
| Finance costs | 2,364 | 3,242 | 13,058 | 13,438 | ||||||||
| Loss (gain) on disposal of property, plant and equipment | 15 | 1,042 | (354 | ) | 935 | |||||||
| Asset impairment(1) | - | - | - | 2,210 | ||||||||
| Income tax expense | 5,696 | 2,788 | 16,097 | 11,694 | ||||||||
| Contract loss provision (recovery)(2) | - | (660 | ) | - | 1,596 | |||||||
| Restructuring and other costs(3) | - | - | 361 | 2,727 | ||||||||
| Adjusted EBITDA | $ | 26,558 | $ | 23,567 | $ | 107,438 | $ | 106,774 | ||||
(1) For the year ended December 31, 2023, the Corporation recognized an asset impairment of
(2) Contract loss provision (recovery) for the three months and year ended December 31, 2023 of
(3) Restructuring and other costs for the year ended December 31, 2024 of
Free Cash Flow
| Three months ended December 31, | Years ended December 31, | |||||||||||
| (000's) | 2024 | 2023 | 2024 | 2023 | ||||||||
| Net cash flows from continuing operating activities | $ | 58,150 | $ | 62,779 | $ | 96,481 | $ | 81,728 | ||||
| Sustaining capital expenditures, net of proceeds from the sale of property, plant and equipment and intangible assets | (1,424 | ) | (600 | ) | (2,754 | ) | (2,625 | ) | ||||
| Finance costs paid | (1,986 | ) | (2,799 | ) | (12,165 | ) | (13,013 | ) | ||||
| Lease payments | (2,039 | ) | (2,247 | ) | (6,882 | ) | (8,307 | ) | ||||
| Free Cash Flow | $ | 52,701 | $ | 57,133 | $ | 74,680 | $ | 57,783 | ||||
Return on Equity
| Years ended December 31, | ||||||
| (000's) | 2024 | 2023 | ||||
| Net earnings from continuing operations | $ | 37,540 | $ | 35,810 | ||
| Average total shareholders' equity(1) | $ | 282,984 | $ | 286,999 | ||
| Return on Equity (%) | 13.3 % | 12.5 % | ||||
(1) Average total shareholders' equity is calculated as the average of beginning total shareholders' equity and ending total shareholders' equity for the year.
Forward-Looking Information
Certain statements contained in this news release may constitute forward-looking information under applicable securities law. Forward-looking information may relate to Dexterra's future outlook and anticipated events, business, operations, financial performance, financial condition or results and, in some cases, can be identified by terminology such as "continue"; "forecast"; "may"; "will"; "project"; "could"; "should"; "expect"; "plan"; "anticipate"; "believe"; "outlook"; "target"; "intend"; "estimate"; "predict"; "might"; "potential"; "continue"; "foresee"; "ensure" or other similar expressions concerning matters that are not historical facts. In particular, statements regarding Dexterra's future operating results and economic performance, including return on equity and Adjusted EBITDA margins; capital allocation priorities, acquisition strategy; its capital light model, market and inflationary environment expectations, asset utilization, camp occupancy levels, its leverage, discontinued operations, FCF, wildfire activity expectations, U.S. tariff impacts, and its objectives and strategies are forward-looking statements. These statements are based on certain factors and assumptions, including expected growth, market recovery, results of operations, performance and business prospects and opportunities regarding Dexterra. While management considers these assumptions to be reasonable based on information currently available to Dexterra, they may prove to be incorrect. Forward-looking information is also subject to certain known and unknown risks, uncertainties and other factors that could cause Dexterra's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information, including, but not limited to: the ability to retain clients, renew existing contracts and obtain new business; an outbreak of contagious disease that could disrupt its business; the highly competitive nature of the industries in which Dexterra operates; outsourcing of services trends; reliance on suppliers and subcontractors; cost inflation; U.S. tariff impacts; volatility of industry conditions could impact demand for its services; a reduction in the availability of credit could reduce demand for Dexterra's products and services; Dexterra's significant shareholder may substantially influence its direction and operations and its interests may not align with other shareholders; its significant shareholder's

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/243611